Prestige Consumer Healthcare Inc. (NYSE: PBH) is a Healthcare company (Medical - Pharmaceuticals) with a market capitalization of $2.3B. The Maz Rating grades it against the other companies in its sector.
Prestige Consumer Healthcare Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $48.22, Prestige Consumer Healthcare Inc. trades at 14.9x trailing earnings, 2.0x sales and 1.2x book value, with an EV/EBITDA of 13.8. Over the last twelve months it generated about $1.2B of revenue and $154M of net income. It runs a gross margin of 52.0%, an operating margin of 25.0% and a net margin of 13.3%. It shows return on equity of 8.2%, return on invested capital of 4.7% and a free cash flow yield of 9.4%. On the balance sheet: a debt-to-equity ratio of 1.09 and a current ratio of 2.92. Over the past 52 weeks the share price ranged from $41.77 to $71.07, with a beta of 0.34.
Prestige Consumer Healthcare Inc. does not currently pay a dividend.
17 Wall Street analyst ratings cover the stock: 11 Buy, 4 Hold and 2 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Prestige Consumer Healthcare Inc. (PBH) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 90.6% / 30% · (Cash+Inv) / Mkt Cap (36m) 2.03% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 90.6% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 2.03% / 33% · Receivables / Mkt Cap (36m) 10.6% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 90.6% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 2.03% / 33.33% · Receivables / Mkt Cap (24m) 10.6% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 37.5% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 1.60% / 33.33% · Receivables / Avg Assets (4Q) 4.98% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 44.0% / 33.33% · (Cash+ST Inv) / Total Assets 0.99% / 33.33% · (Cash+Recv) / Total Assets 6.16% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Prestige Consumer Healthcare Inc. (PBH) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Prestige Consumer Healthcare Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m).
Prestige Consumer Healthcare Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q2 2027). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.